Company / Revenue
Catalyst Pharmaceuticals Partners, Inc. Revenue History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue
$589.0M
FY2025
5-year range
$140.8M / $589.0M
FY2021-FY2025
Trend
+19.8%
vs FY2024
Sector context
#62 of 155
Health Care
What the data says
At $589M, Catalyst Pharmaceuticals Partners, Inc.'s revenue ranks #62 of 155 in the Health Care sector. Revenue has increased for 8 consecutive years, from $0 in FY2017 to $589M in FY2025.
Based on SEC 10-K filings.
$589M in FY2025 with a 5-year CAGR of +37.7%.
Improved from $398M to $589M over the past 2 years.
Health Care sector context is included.
Revenue over time
Growth rates
- 3-Year CAGR
- +40.1%
- 5-Year CAGR
- +37.7%
- 10-Year CAGR
- -
Sector benchmark
#62 of 155 in Health CareTop 40% of 155This company $589.0M Sector average $4.5B
▼
-86.8% below sector average
Key checks
Key Insights
- Catalyst Pharmaceuticals Partners, Inc.'s revenue has grown for 7 consecutive years.
- 5-year CAGR of +37.7%, indicating consistent growth.
- In FY2025, revenue increased 19.8% year-over-year.
- Ranks #62 out of 155 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 4.78 (safe zone, above 2.9 threshold)
- Strong profit margin: 33.3%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $589.0M | +19.8% |
| FY2024 | $491.7M | +23.5% |
| FY2023 | $398.2M | +85.9% |
| FY2022 | $214.2M | +52.1% |
| FY2021 | $140.8M | +18.3% |
| FY2020 | $119.1M | +16.4% |
| FY2019 | $102.3M | +20361.3% |
| FY2018 | $500.0K | - |
| FY2017 | $0 | - |
| FY2016 | $0 | - |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026